title: Liposomal cytarabine in cerebrospinal fluid.
authors.affiliation: Department of Haemato-Oncology, The Royal Marsden Hospital, Downs Road, Sutton, Surrey, UK. Kevin.boyd@icr.ac.uk
authors.forename: Kevin
authors.initials: K
authors.lastname: Boyd
authors.forename: Matthew
authors.initials: M
authors.lastname: Jenner
authors.forename: Jennie
authors.initials: J
authors.lastname: Treleaven
authors.forename: Jackie
authors.initials: J
authors.lastname: Kenny
authors.forename: Elaine
authors.initials: E
authors.lastname: Rhoades
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002051:Burkitt Lymphoma / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007278:Injections, Spinal; D008081:Liposomes; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D008081:Liposomes; D003561:Cytarabine; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D008727:Methotrexate